Seroxat is also known as Paxil and Aropax. Blog exposes Bob Fiddaman Human rights abuser who won two SCIENTOLOGY CCHR (human rights!) awards.
blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1
This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1
Saturday, 20 June 2009
Remembering Stefan Kiszko - fitted up by the police because he had been put on testosterone injections by the doctor shortly before the Molseed murder
Police were convinced he was responsible for the horrific crime because he had been put on testosterone injections by the doctor shortly before the killing.There was also an allegation, which was later proved to be a lie, that he had exposed himself to a group of teenage girls and "girlie magazines" had been found in his car.Lawyer Campbell Malone and private detective Peter Jackson continued to campaign for a fresh investigation highlighting a series of problems
prevalence of sex chromosome trisomies - previously thought to be 1 in 1000 has risen to near 1 in 550
Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and the London, Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK. j.k.morris@qmul.ac.uk
http://www.ncbi.nlm.nih.gov/pubmed/18000523
The birth prevalence of sex chromosome trisomies (SCT), that is individuals with an XYY, XXY or XXX sex chromosome constitution, is traditionally based on six surveys of unselected newborns carried out in the 1960s and early 1970s. All three SCTs had a prevalence of 1 in 1000 same sex births. We re-examined these prevalences based on additional cytogenetic studies of newborn surveys, spontaneous abortions, perinatal deaths and prenatal diagnoses. The more recent newborn surveys suggest there has been an increase in the prevalence of XXYs, but not of the other two SCTs since the original newborn series. The prevalence of XXYs has risen from 1.09 to 1.72 per 1000 male births (P=0.023). We suggest that such an increase, in the absence of an increase in the prevalence of XXX, is unlikely to be due to increased maternal age. As XXY is the only chromosome abnormality known where a substantial proportion ( approximately 50%) arise as the result of non-disjunction at the first paternal meiotic division, we speculate that some factor may be interfering with pairing and/or recombination of the sex bivalent at the paternal MI division.
PMID: 18000523 [PubMed - indexed for MEDLINE
http://www.ncbi.nlm.nih.gov/pubmed/18000523
The birth prevalence of sex chromosome trisomies (SCT), that is individuals with an XYY, XXY or XXX sex chromosome constitution, is traditionally based on six surveys of unselected newborns carried out in the 1960s and early 1970s. All three SCTs had a prevalence of 1 in 1000 same sex births. We re-examined these prevalences based on additional cytogenetic studies of newborn surveys, spontaneous abortions, perinatal deaths and prenatal diagnoses. The more recent newborn surveys suggest there has been an increase in the prevalence of XXYs, but not of the other two SCTs since the original newborn series. The prevalence of XXYs has risen from 1.09 to 1.72 per 1000 male births (P=0.023). We suggest that such an increase, in the absence of an increase in the prevalence of XXX, is unlikely to be due to increased maternal age. As XXY is the only chromosome abnormality known where a substantial proportion ( approximately 50%) arise as the result of non-disjunction at the first paternal meiotic division, we speculate that some factor may be interfering with pairing and/or recombination of the sex bivalent at the paternal MI division.
PMID: 18000523 [PubMed - indexed for MEDLINE
Friday, 19 June 2009
Paxil - Seroxat - these men, one of them Mark Harvey's expert witness show Seroxat is the fastest declining SSRI of all time.
Dr David Healy charged Seroxat clients £500 to read their medical notes
Seroxat - this is the man who tried to show that paroxetine is more difficult to withdraw from than all other SSRI's (spelling errors as per original)

Does Seroxat have a capacity to cause asverse effects consequent upon or following discontinuance (withdrawl) such as prevent or make more difficult the ability of users to discontinue, withdraw from or remain free from taking Seroxat to a greater extent than all other Selective Serotonin Re-uptake Inhibitors (SSRIs)
Seroxat decline - media & other awareness events - Fiddaman if you don't like this conclusion consider yourself a victim of your own propaganda

Conclusions.
Chart 5 demonstrates the immense value to Society of free and independent Public Service
Broadcasting and Internet communication. This combination has triggered the growth of
awareness of SSRI danger. It has united the many thousands of victims of SSRIs across the
world with some professionals who have laboured so long in a cause for saving lives, seeking
justice and exposing dysfunctional drug regulation. Chart 5 shows that the tide has turned in
the UK. Great encouragement should be taken from this life saving victory. However efforts
must continue both to expose the known risks of paroxetine (Seroxat, Paxil) and all the other ill
validated SSRIs and to call for the establishment an effective independent Drug Safety
Regulator in every country, the absence of which is the root cause of this ongoing officially
supported tragedy.
======================================================
Seroxat Group Litigation Defining Issues - Mark Harvey's litigation all washed up following revelations of Healy & Aldred

Defining Issues:
Defining Issues:-Does Seroxat have a capacity to cause asverse effects consequent upon or following discontinuance (withdrawl) such as prevent or make more difficult the ability of users to discontinue, withdraw from or remain free from taking Seroxat to a greater extent than all other Selective Serotonin Re-uptake Inhibitors (SSRIs)
http://www.hmcourts-service.gov.uk/cms/150_14671.htm
Seroxat declined 36% from Q4 2001 to Q42003 - that is a lot of UK people getting off without any specialist help
if the higher precision quarterly data is used; from the peak at Q4 2001 to Q42003 the fall was 36%.
http://www.ahrp.org/COI/PaxilDeclineUK.pdf
http://www.ahrp.org/COI/PaxilDeclineUK.pdf
Paxil Seroxat's Graham Aldred who worked with Dr Healy shows - massive decline in Seroxat consumption - without any withdrawal clinics

The Decline of use of Paroxetine in England
Parox Hist14.doc GA19/05/04
3
IMR uses the common medication unit called TWS, (Two Weeks Supply), this enables the
medication to be accumulated under one universal label regardless of form or concentration.
Chart 2 was plotted using annual data, rather than quarterly data. It shows that the annual
consumption of paroxetine in all its forms grew by more than 1.15 million units per year for 7
years up to 2001, then it fell by 2.7 M units i.e. 25% from 2001 to 2003. In fact this decline is
much worse if the higher precision quarterly data is used; from the peak at Q4 2001 to Q4
2003 the fall was 36%. Annual totals can disguise higher rates of change defined by the
quarters within the years (frequently exploited in financial marketing.)
Parox Hist14.doc GA19/05/04
3
IMR uses the common medication unit called TWS, (Two Weeks Supply), this enables the
medication to be accumulated under one universal label regardless of form or concentration.
Chart 2 was plotted using annual data, rather than quarterly data. It shows that the annual
consumption of paroxetine in all its forms grew by more than 1.15 million units per year for 7
years up to 2001, then it fell by 2.7 M units i.e. 25% from 2001 to 2003. In fact this decline is
much worse if the higher precision quarterly data is used; from the peak at Q4 2001 to Q4
2003 the fall was 36%. Annual totals can disguise higher rates of change defined by the
quarters within the years (frequently exploited in financial marketing.)
Seroxat Panorama - Graham Aldred reassured his wife that Seroxat was safe
http://news.bbc.co.uk/1/hi/programmes/panorama/3707900.stm
Graham Aldred reassured his wife that Seroxat was safe
Graham Aldred reassured his wife that Seroxat was safe
Graham Aldred's wife Rhona was prescribed Seroxat for depression in 2001. She was depressed and anxious but not suicidal.
She wasn't keen to take it at first, but her husband reassured her.
He said: "When Rhona brought the drug home she said to me she had some reservations about it and I said, 'don't be silly, this is England, this is a country where you can trust medical regulation'.
"Now she was right and I was wrong."
However, shortly after starting on Seroxat, Rhona became very restless, agitated and had terrible nightmares. After 11 days on the drug, she drove to a secluded country lane, and killed herself.
Graham told the programme: "This is what the Regulator doesn't seem to understand - that there are people on the end of all this."
She wasn't keen to take it at first, but her husband reassured her.
He said: "When Rhona brought the drug home she said to me she had some reservations about it and I said, 'don't be silly, this is England, this is a country where you can trust medical regulation'.
"Now she was right and I was wrong."
However, shortly after starting on Seroxat, Rhona became very restless, agitated and had terrible nightmares. After 11 days on the drug, she drove to a secluded country lane, and killed herself.
Graham told the programme: "This is what the Regulator doesn't seem to understand - that there are people on the end of all this."
Seroxat Paxil - "The Decline of use of Paroxetine in England" - paper by Graham Aldred 17 May 2004

Official drug statistics for England show that the use of paroxetine in England grew annually
for the first 11 years since 1991 in spite of the increasing weight of scientific and clinical
evidence that this drug does induce suicide in some and dependence in others. Annual
consumption of all forms of paroxetine peaked in Q4 2001 it but Q4 2003 it had fallen by 25%.
Some reasons for the growth in patient awareness and rejection of Seroxat are examined in this
paper.
for the first 11 years since 1991 in spite of the increasing weight of scientific and clinical
evidence that this drug does induce suicide in some and dependence in others. Annual
consumption of all forms of paroxetine peaked in Q4 2001 it but Q4 2003 it had fallen by 25%.
Some reasons for the growth in patient awareness and rejection of Seroxat are examined in this
paper.
SSRI DISCUSSION FORUM: Could Seroquel liability suits be a bust?
SSRI DISCUSSION FORUM: Could Seroquel liability suits be a bust?: "Could Seroquel liability suits be a bust?
June 18 2009 at 10:47 PMAnonymous
Could Seroquel liability suits be a bust?
June 18, 2009 11:25am ET By Tracy Staton
http://www.fiercepharma.com/story/could-seroquel-liability-suits-be-bust/2009-06-18
No surprise that the legal community is closely watching AstraZeneca's ongoing defense in Seroquel product-liability suits. After all, the pharma biz keeps plenty of lawyers in full employment, between torts and patents and regulatory matters. So it's also no surprise that, when Litigation Daily proclaimed the Seroquel troubles a 'mass tort that wasn't,' plaintiff's lawyers came out of the woodwork to protest."
June 18 2009 at 10:47 PMAnonymous
Could Seroquel liability suits be a bust?
June 18, 2009 11:25am ET By Tracy Staton
http://www.fiercepharma.com/story/could-seroquel-liability-suits-be-bust/2009-06-18
No surprise that the legal community is closely watching AstraZeneca's ongoing defense in Seroquel product-liability suits. After all, the pharma biz keeps plenty of lawyers in full employment, between torts and patents and regulatory matters. So it's also no surprise that, when Litigation Daily proclaimed the Seroquel troubles a 'mass tort that wasn't,' plaintiff's lawyers came out of the woodwork to protest."
Thursday, 18 June 2009
Let them eat Prozac: the unhealthy ... - Google Books

David Healy's first meeting with Scientology ambulance chasing lawyers
Let them eat Prozac: the unhealthy ... - Google Books
Let them eat Prozac: the unhealthy ... - Google Books
Wednesday, 17 June 2009
SSRI DISCUSSION FORUM: Report on Gene for Depression Is Now Faulted
SSRI DISCUSSION FORUM: Report on Gene for Depression Is Now Faulted: "Report on Gene for Depression Is Now Faulted
June 17 2009 at 10:45 PMAnonymous
http://www.nytimes.com/2009/06/17/science/17depress.html?ref=global-home
By BENEDICT CAREY Published: June 16, 2009
One of the most celebrated findings in modern psychiatry that a single gene helps determine ones risk of depression in response to a divorce, a lost job or another serious reversal has not held up to scientific scrutiny, researchers reported Tuesday.
The original finding, published in 2003, created a sensation among scientists and the public because it offered the first specific, plausible explanation of why some people bounce back after a stressful life event while others plunge into lasting despair."
The new report, by several of the most prominent researchers in the field, does not imply that interactions between genes and life experience are trivial; they are almost certainly fundamental, experts agree.
But it does suggest that nailing down those factors in a precise way is far more difficult than scientists believed even a few years ago, and that the original finding could have been due to chance. The new report is likely to inflame a debate over the direction of the field itself, which has found that the genetics of illnesses like schizophrenia and bipolar disorder remain elusive.
This gene/life experience paradigm has been very influential in psychiatry, both in the studies people have done and the way data has been interpreted, said Dr. Kenneth S. Kendler, a professor of psychiatry and human genetics at Virginia Commonwealth University, and I think this paper really takes the wind out of its sails.
Others said the new analysis was unjustifiably dismissive. What is needed is not less research into gene-environment interaction, Avshalom Caspi, a neuroscientist at Duke University and lead author of the original paper, wrote in an e-mail message, but more research of better quality.
The original study was so compelling because it explained how nature and nurture could collude to produce a complex mood problem. It followed 847 people from birth to age 26 and found that those most likely to sink into depression after a stressful event job loss, sexual abuse, bankruptcy had a particular variant of a gene involved in the regulation of serotonin, a brain messenger that affects mood. Those in the study with another variant of the gene were significantly more resilient.
I think what happened is that people whod been working in this field for so long were desperate to have any solid finding, Kathleen R. Merikangas, chief of the genetic epidemiology research branch of the National Institute of Mental Health and senior author of the new analysis, said in a phone interview. It was exciting, and some people thought it was the finding in psychiatry, a major advance.
The excitement spread quickly. Newspapers and magazines reported the finding. Columnists, commentators and op-ed writers emphasized its importance. The study provided some despairing patients with comfort, and an excuse Well, it is in my genes. It reassured some doctors that they were medicating an organic disorder, and stirred interest in genetic testing for depression risk.
Since then, researchers have tried to replicate the gene finding in more than a dozen studies. Some found similar results; others did not. In the new study, being published Wednesday in The Journal of the American Medical Association, Neil Risch of the University of California, San Francisco, and Dr. Merikangas led a coalition of researchers who identified 14 studies that gathered the same kinds of data as the original study. The authors reanalyzed the data and found no evidence of an association between the serotonin gene and the risk of depression, no matter what peoples life experience was, Dr. Merikangas said.
By contrast, she said, a major stressful event, like divorce, in itself raised the risk of depression by 40 percent.
The authors conclude that the widespread acceptance of the original findings was premature, writing that it is critical that health practitioners and scientists in other disciplines recognize the importance of replication of such findings before they can serve as valid indicators of disease risk or otherwise change practice.
Dr. Caspi and other psychiatric researchers said it would be equally premature to abandon research into gene-environment interaction, when brain imaging and other kinds of evidence have linked the serotonin gene to stress sensitivity.
This is an excellent review paper, no one is questioning that, said Myrna Weissman, a professor of epidemiology and psychiatry at Columbia. But it ignored extensive evidence from humans and animals linking excessive sensitivity to stress to the serotonin gene.
Dr. Merikangas said she and her co-authors deliberately confined themselves to studies that could be directly compared to the original. We were looking for replication, she said.
June 17 2009 at 10:45 PMAnonymous
http://www.nytimes.com/2009/06/17/science/17depress.html?ref=global-home
By BENEDICT CAREY Published: June 16, 2009
One of the most celebrated findings in modern psychiatry that a single gene helps determine ones risk of depression in response to a divorce, a lost job or another serious reversal has not held up to scientific scrutiny, researchers reported Tuesday.
The original finding, published in 2003, created a sensation among scientists and the public because it offered the first specific, plausible explanation of why some people bounce back after a stressful life event while others plunge into lasting despair."
The new report, by several of the most prominent researchers in the field, does not imply that interactions between genes and life experience are trivial; they are almost certainly fundamental, experts agree.
But it does suggest that nailing down those factors in a precise way is far more difficult than scientists believed even a few years ago, and that the original finding could have been due to chance. The new report is likely to inflame a debate over the direction of the field itself, which has found that the genetics of illnesses like schizophrenia and bipolar disorder remain elusive.
This gene/life experience paradigm has been very influential in psychiatry, both in the studies people have done and the way data has been interpreted, said Dr. Kenneth S. Kendler, a professor of psychiatry and human genetics at Virginia Commonwealth University, and I think this paper really takes the wind out of its sails.
Others said the new analysis was unjustifiably dismissive. What is needed is not less research into gene-environment interaction, Avshalom Caspi, a neuroscientist at Duke University and lead author of the original paper, wrote in an e-mail message, but more research of better quality.
The original study was so compelling because it explained how nature and nurture could collude to produce a complex mood problem. It followed 847 people from birth to age 26 and found that those most likely to sink into depression after a stressful event job loss, sexual abuse, bankruptcy had a particular variant of a gene involved in the regulation of serotonin, a brain messenger that affects mood. Those in the study with another variant of the gene were significantly more resilient.
I think what happened is that people whod been working in this field for so long were desperate to have any solid finding, Kathleen R. Merikangas, chief of the genetic epidemiology research branch of the National Institute of Mental Health and senior author of the new analysis, said in a phone interview. It was exciting, and some people thought it was the finding in psychiatry, a major advance.
The excitement spread quickly. Newspapers and magazines reported the finding. Columnists, commentators and op-ed writers emphasized its importance. The study provided some despairing patients with comfort, and an excuse Well, it is in my genes. It reassured some doctors that they were medicating an organic disorder, and stirred interest in genetic testing for depression risk.
Since then, researchers have tried to replicate the gene finding in more than a dozen studies. Some found similar results; others did not. In the new study, being published Wednesday in The Journal of the American Medical Association, Neil Risch of the University of California, San Francisco, and Dr. Merikangas led a coalition of researchers who identified 14 studies that gathered the same kinds of data as the original study. The authors reanalyzed the data and found no evidence of an association between the serotonin gene and the risk of depression, no matter what peoples life experience was, Dr. Merikangas said.
By contrast, she said, a major stressful event, like divorce, in itself raised the risk of depression by 40 percent.
The authors conclude that the widespread acceptance of the original findings was premature, writing that it is critical that health practitioners and scientists in other disciplines recognize the importance of replication of such findings before they can serve as valid indicators of disease risk or otherwise change practice.
Dr. Caspi and other psychiatric researchers said it would be equally premature to abandon research into gene-environment interaction, when brain imaging and other kinds of evidence have linked the serotonin gene to stress sensitivity.
This is an excellent review paper, no one is questioning that, said Myrna Weissman, a professor of epidemiology and psychiatry at Columbia. But it ignored extensive evidence from humans and animals linking excessive sensitivity to stress to the serotonin gene.
Dr. Merikangas said she and her co-authors deliberately confined themselves to studies that could be directly compared to the original. We were looking for replication, she said.
Will Mark Harvey ("Hugh James is working" with US attorneys) - become the first UK solicitor peanalised for ambulance chasing &

US attorneys (with whom
Hugh James is working)
have succeeded in
obtaining a temporary
court order to ban Glaxo
SmithKline from
advertising Seroxat on
television with the motto
"non-habit forming". The
Judge will hold a full
hearing in October to
consider the matter
further. However not
only is the Judge's
decision criticised by
GSK but the US Food
and Drugs
Administration also
argues that the court
exceeded its powers.
http://www.seroxatusergroup.org.uk/Documents/newsletterissue1.pdf
Hugh James is working)
have succeeded in
obtaining a temporary
court order to ban Glaxo
SmithKline from
advertising Seroxat on
television with the motto
"non-habit forming". The
Judge will hold a full
hearing in October to
consider the matter
further. However not
only is the Judge's
decision criticised by
GSK but the US Food
and Drugs
Administration also
argues that the court
exceeded its powers.
http://www.seroxatusergroup.org.uk/Documents/newsletterissue1.pdf
Seroxat US Scientology lawyer George W. "Skip" Murgatroyd - penalized for his illegal ambulance-chasing and solicitation of clients

SEROXAT SUFFERERS - STAND UP AND BE COUNTED: Seroxat Scientology lawyer George W. "Skip" Murgatroyd - penalized for his illegal ambulance-chasing and solicitation of clients: "The Indiana Bar penalized Murgatroyd for his illegal ambulance-chasing and solicitation of clients within the state of Indiana. He is not the only Scientology crime cultist lawyer sanctioned for blatant ambulance-chasing. John Coale, husband of Greta van Susteren, also shares this dubious honor."
Tuesday, 16 June 2009
What does Fiddaman NOT understand - Suicide "there was a Class Phenomenon" & "successful litigation was unlikely"
"We found some time ago that there was a Class Phenomenon for suicidal ideation and acts which meant that, together with other notable problems both in science and in law, successful litigation was unlikely."
-
If Mr Harvey thinks that this is an unfair representation of his own words then he can apply to have this blog taken down or this post removed.
-
Remember he wrote to Bob Fiddaman on behalf of GSK's lawyers Addleshaw Goddard
Fiddaman was forced to apologise in public for his conduct & take down offending material.
Subscribe to:
Posts (Atom)



